Press release
Human Insulin Market Size, Share, Trends, Growth and Forecast 2023-2028
Human insulin (HI), or regular insulin, is a short-acting form of insulin naturally occurring in the human body and is typically administered through subcutaneous injections several times a day. It is employed to treat hyperglycemia caused due to type 1 and type 2 diabetes. It is manufactured by recombinant deoxyribonucleic acid (DNA) technology and is identical to endogenously made insulin. It is bio-engineered by growing insulin proteins cultivated within E-coli bacteria (Escherichia coli) cells. Additionally, it facilitates the uptake of glucose from the bloodstream into internal organs and tissues, including the liver and fat cells, to use as energy. It also inhibits the production of glucose in the liver and promotes protein synthesis within the body to use as energy. Currently, manufacturers are introducing an inhalable variant specifically developed to serve as a meal-time bolus insulin. As a result, human insulin (HI) is easily available in retail and hospital pharmacies and online retail stores across the globe.
Request Your Sample Report Now: https://www.imarcgroup.com/human-insulin-market/requestsample
Human Insulin Market Trends and Drivers:
The market is primarily driven by the increasing occurrences of diabetes due to sedentary lifestyles, geriatric population, and unhealthy dietary habits. Additionally, the growing awareness among consumers about the complications associated with long-term diabetes, such as heart attacks, cataracts, and kidney failure, is contributing to the market growth. In line with this, the rising demand for biosimilar drugs due to their effectiveness and cost-efficiency is influencing market growth. Moreover, the introduction of pen devices and safety pen needles, which minimize discomfort and reduce the risks of infections, injuries, and transmission of bloodborne pathogens, represents another major growth-inducing factor. Besides this, the implementation of stringent government regulations to prevent needle stick injuries and the shift in consumer preferences toward minimally invasive (MI) devices have promoted the use of pen devices and safety pen needles for delivering human insulin, thus accelerating the product adoption rate. Along with this, recent advancements in biotechnology, ongoing product innovations, and the development of novel insulin products are propelling market growth. For instance, in May 2022, Eli Lilly and Company obtained approval for the Mounjaro injection, a treatment that facilitates the improvement of glycemic control in individuals diagnosed with type 2 diabetes. Apart from this, human insulin (HI) is growing at different rates in numerous regions, with North America being one of the largest markets due to a sedentary lifestyle, rising occurrences of diabetes, and several technological advancements. Moreover, the industry is expected to face competition in the upcoming years as various key players are implementing competitive strategies to sustain their presence in the market. For instance, in June 2020, the U.S. Food and Drug Administration granted approval to Lyumjev, a rapid-acting insulin developed by Eli Lilly and Company to enhance glycemic control in adults diagnosed with type 1 and type 2 diabetes. Furthermore, improving healthcare infrastructure, increasing consumer health consciousness, and extensive investment in research and development (R&D) activities to develop oral insulin variants that offer an effective, safe, and convenient are creating a positive market outlook.
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
B. Braun Melsungen AG
Becton
Dickinson and Company (BD)
Biocon
Eli Lilly and Company
Gulf Pharmaceutical Industries (Julphar)
Novo Nordisk A/S
Pfizer Inc.
Groupe Sanofi
SEDICO Co.
Wockhardt Limited
Ypsomed AG
Explore full report with table of contents: https://www.imarcgroup.com/human-insulin-market
The report has segmented the market on the basis of Product Type, End-User and Region.
Breakup by Product Type:
Drugs
Human Insulin Analogs and Biosimilars
Rapid Acting
Long Acting
Premixed
Human Insulin Biologics
Short Acting
Intermediate Acting
Premixed
Delivery Devices
Pens
Reusable Pens
Disposable Pens
Pen Needles
Standard Pen Needles
Safety Pen Needles
Syringes
Others
Breakup by Distribution Channel:
Retail Pharmacies
Hospital Pharmacies
Online Retail Stores
Others
Breakup by Disease Type:
Type I Diabetes
Type II Diabetes
Market Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Human Insulin Market Size, Share, Trends, Growth and Forecast 2023-2028 here
News-ID: 3213219 • Views: …
More Releases from IMARC Group
Indonesia Lubricants Market Size, Share, Trends, Growth Insights, Forecast Repor …
As indicated in the latest market research report published by IMARC Group, titled "Indonesia Lubricants Market Report by Product Type (Engine Oils, Greases, Hydraulic Fluids, Metalworking Fluids, Transmission and Gear Oils, and Others), End User (Automotive, Heavy Equipment, Metallurgy and Metalworking, Power Generation, and Others), and Region 2025-2033," this report provides an in-depth analysis of the industry, featuring insights into the market. It encompasses competitor and regional analyses, as well…
Bamboo Fiber Manufacturing Plant Cost 2025: Layout, Machinery, Raw Materials, an …
Bamboo fiber is a natural, eco-friendly textile material extracted from bamboo pulp through mechanical or chemical processing. Known for its softness, breathability, and antibacterial properties, it serves as a sustainable alternative to cotton and synthetic fibers. Bamboo fiber is widely used in textiles, home furnishings, hygiene products, and industrial applications. Its natural moisture absorption and biodegradability make it highly desirable for environmentally conscious consumers and industries seeking renewable raw materials…
Indonesia Lubricants Market Size, Share, Trends, Growth Insights, Forecast Repor …
As indicated in the latest market research report published by IMARC Group, titled "Indonesia Lubricants Market Report by Product Type (Engine Oils, Greases, Hydraulic Fluids, Metalworking Fluids, Transmission and Gear Oils, and Others), End User (Automotive, Heavy Equipment, Metallurgy and Metalworking, Power Generation, and Others), and Region 2025-2033," this report provides an in-depth analysis of the industry, featuring insights into the market. It encompasses competitor and regional analyses, as well…
Indonesia Coal Market Size, Share, Growth Insights, Trends Analysis & Report 202 …
As indicated in the latest market research report published by IMARC Group, titled "Indonesia Coal Market Report by Application (Electricity, Iron and Steel Industry, Others), Region (Java, Sumatra, Kalimantan, Sulawesi, Others) 2025-2033," this report provides an in-depth analysis of the industry, featuring insights into the market. It encompasses competitor and regional analyses, as well as recent advancements in the market.
Market Size & Future Growth Potential:
The Indonesia coal market size reached…
More Releases for Human
Global Human Augmentation Market 2024-2031: Advancing Human Potential Through Te …
Global Human Augmentation Market reached US$ 252.6 Billion in 2023 and is expected to reach US$ 780.7 Billion by 2031, growing with a CAGR of 15.6% during the forecast period 2024-2031.
The Human Augmentation Market focuses on technologies enhancing human capabilities through wearable exoskeletons, neural interfaces, prosthetics, and performance-enhancing devices. Growth is fueled by medical rehabilitation, industrial automation, defense applications, and lifestyle technology. Advances in robotics, AI, and brain-computer interfaces expand…
Human Factors and Usability Engineering Services Market Key Players Analysis - H …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Human Factors and Usability Engineering Services Market"-, By Steps Involved (Summative Study, Contextual Analysis, Formative Study, Known Use Error Analysis, Use Risk Analysis, Submission Preparation, Design Process and Task Analysis), By Type of Research Method (Evaluation Research and Generative Research), Class of Medical Device Tested (Class I, Class II and Class III ), Industry Trends, and…
Defending Human Life
Albert Covarrubias, Jr was fighting for his Constitutional rights and was killed in the line of duty by his own police force. There is no divine right to kill him for simply standing up for his rights. Every person has the right to stand for what they believe, rather than be gunned down. You cannot take away human life as being ok with simply saying it was a mistake.
If someone…
The Human Whisperer
'The Human Whisperer'
Finlay McArthur
Published in Austin Macauley Publishers Ltd on 30th of June 2020, both in paperback and eBook version.
The Human Whisperer is the second book by Finlay on his quest to give his readers a better understanding of life. This book will help the reader understand that as humans, there is so much more to us than we think. We are connected to the world both physically and…
Human Physiology 2019
Human Physiology 2019
Theme: Exploring the Principles of Physiology & Metabolism
September 16-17, 2019 | London, United Kingdom
Lexis Conferences cordially invites all the members of different nations to attend this annual meet which is scheduled to hold on September 16-17, 2019 at London, United Kingdom based on theme Exploring the Principles of Physiology & Metabolism. A two days scientific meet will gather scientists, students and healthcare industries under one roof to build…
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our…
